Early post-marketing surveillance and case reports raised initial concerns, prompting extensive investigation through randomised controlled trials, observational studies, and meta-analyses
Lab-Tested for Quality and Consistency Tested every 3 to 6 months to confirm that the active ingredient falls within 10% of its intended concentration
Sarrauste de Menthiere C, Chavanieu A, Grassy G, et al
Emerging approaches for deciphering endothelial metabolism under aging and shear stress EC metabolism, particularly under aging and changes in flow patterns and associated shear stress, exhibits distinct characteristics that are insufficiently understood due to the limitations of traditional in vitro methods
Quick Answer: Metformin does not directly cause blurry vision but blood glucose fluctuations during treatment create osmotic changes in the eye's lens, temporarily altering its shape and causing refractive vision changes that typically resolve within 6-8 weeks
This class of medicines first obtained FDA approval in 2005 for Byetta (exenatide, then Amylin) with indications for the treatment of type 2 diabetes